Recurrent statin-induced rhabdomyolysis: Commonly overlooked drug. Indian Journal of Case Reports, [S. l.], v. 10, n. 2, p. 54–55, 2024. DOI: 10.32677/ijcr.v10i2.4299. Disponível em: https://mansapublishers.com/ijcr/article/view/4299. Acesso em: 5 dec. 2025.